The global overactive bladder treatment market size was worth $4.3B in 2021 and is projected to reach $ 5.3B by 2028 at a CAGR of 3.1% by 2028, according to a report by The Insight Partners.
The growth of the global overactive bladder treatment market is primarily attributed to the increasing prevalence of urinary incontinence and the growing incidence of urinary tract infections. However, the recalls of therapeutic drugs hamper the market growth.
In 2021, North America held the largest share of the overactive bladder treatment market. The growing prevalence of overactive bladder in the geriatric population and the increasing incidence of neurological diseases are propelling the growth of the overactive bladder treatment market in North America. Also, the suitable reimbursement scenarios for the treatment of overactive bladder and the increase in research activities fuel the growth of the North America market. According to the Cleveland Clinic Organization, about 33 million adults in the US are affected by an overactive bladder.